Spanish Network for Research in Infectious Diseases
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
9.1%
1 terminated/withdrawn out of 11 trials
88.9%
+2.4% vs industry average
55%
6 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins
Role: collaborator
Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
Role: collaborator
Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia
Role: collaborator
Proadrenomedullin and Copeptin in Patients With Septic Shock
Role: lead
Adverse Events in the Tracheal Intubation in the Intensive Care Unit
Role: lead
Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae
Role: collaborator
Immunosupressive Treatment in COVID-19 Patients
Role: lead
Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli
Role: collaborator
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Role: lead
Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination
Role: collaborator
"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
Role: collaborator
All 11 trials loaded